Transaction #38278 · Form 4 · 0002162845-26-000005
Tarsus Pharmaceuticals, Inc. · Stock award · Restricted Stock Units
Tarsus Pharmaceuticals, Inc. · Transacted November 3, 2026 · Filed November 5, 2026
What does this filing report?
An SEC Form 4 filing for Tarsus Pharmaceuticals, Inc. records a stock award involving Restricted Stock Units on November 3, 2026. The reported quantity was 6,678. The filing date is November 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Tarsus Pharmaceuticals, Inc.
- Company CIK
- 0001819790
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 6,678
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 6,678
- Ownership description
- Not reported
- SEC acceptance time
- Nov 5, 2026, 4:40 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Clase Neera ↗
Chief Commercial Officer
CIK 0002162845
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 6,678
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- 25% of the option shares shall vest on November 1, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.
- F2
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- F3
- The RSUs will vest in four equal annual installments on December 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.